"Kaplan is a premier provider of educational and career services for individuals, schools and businesses. Established in 1938, Kaplan is the world leader in the test prep industry. With a comprehensive menu of online offerings as well as a complete array of print books and digital products, Kaplan offers preparation, and private tutoring for more than 100 standardized tests including SAT, ACT, LSAT, MCAT, GRE, GMAT, USMLE, NCLEX, BAR."

During the past decade, Kaplan Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaplan Cancer Center" #1 sponsor was "NYU Langone Health" with 7 trials, followed by "Radiation Therapy Oncology Group" with 7 trials sponsored, "Children's Oncology Group" with 6 trials sponsored, "Eastern Cooperative Oncology Group" with 4 trials sponsored and "National Cancer Institute (NCI)" with 4 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaplan Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Children's Cancer Group" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Kaplan Cancer Center" are "Leukemia" (7 trials), "Lung Cancer" (3 trials), "Lymphoma" (3 trials), "Prostate Cancer" (3 trials) and "Sarcoma" (3 trials). Many other conditions were trialed in "Kaplan Cancer Center" in a lesser frequency.

Most popular intervention types in "Kaplan Cancer Center" are "Drug" (30 trials), "Radiation" (12 trials), "Biological" (10 trials), "Procedure" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (7 trials), "low-LET photon therapy" (7 trials), "filgrastim" (6 trials), "low-LET cobalt-60 gamma ray therapy" (6 trials) and "vincristine sulfate" (6 trials). Other intervention names were less common.

The vast majority of trials in "Kaplan Cancer Center" are 28 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kaplan Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Kaplan Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaplan Cancer Center, 7 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".